免疫蛋白质组学与反向疫苗学鉴定Fonsecaea pedrosoi保护性T细胞表位用于着色芽生菌病疫苗开发
本研究采用免疫蛋白质组学与反向疫苗学相结合的策略,从着色芽生菌病主要致病菌Fonsecaea pedrosoi中鉴定免疫原性抗原。通过二维电泳和感染小鼠血清识别抗原蛋白,质谱鉴定出包括烯醇化酶和若干未知功能蛋白在内的抗原;计算表位预测发现肽段Hp11696(LGFMSAFKASKLIAI)对MHC II类分子具有高预测亲和力。功能实验显示Hp11696可刺激感染动物脾细胞中抗原特异性CD4+ T细胞增殖;小鼠模型免疫接种Hp11696显著降低真菌负荷,并诱导以IFN-γ和IL-10升高为特征的细胞因子应答。
要点
- Hp11696肽段可刺激感染动物脾细胞中抗原特异性CD4+ T细胞增殖。
- Hp11696免疫显著降低着色芽生菌病小鼠模型中的真菌负荷。
- Hp11696免疫诱导IFN-γ和IL-10产生增加。
核心结论
- 免疫蛋白质组学引导的抗原发现可从真菌病原体中鉴定保护性肽表位。
- Hp11696肽段是开发针对着色芽生菌病肽基疫苗的有前景候选。
研究设计与样本
- 采用免疫蛋白质组学与反向疫苗学相结合的方法鉴定F. pedrosoi免疫原性抗原。
- 真菌蛋白经二维电泳分离,用感染小鼠血清检测免疫反应蛋白,质谱鉴定抗原蛋白。
- 计算表位预测筛选MHC II类分子高亲和力肽段,并在感染动物脾细胞和小鼠模型中评估免疫原性与保护效果。
主要发现
- 质谱鉴定出包括烯醇化酶和先前未表征的假想蛋白在内的多种抗原蛋白。
- 计算表位预测发现肽段Hp11696(LGFMSAFKASKLIAI)对MHC II类分子具有高预测亲和力。
- Hp11696刺激感染动物脾细胞中抗原特异性CD4+ T细胞增殖。
- Hp11696免疫显著降低着色芽生菌病小鼠模型中的真菌负荷。
- Hp11696免疫诱导以IFN-γ和IL-10产生增加为特征的细胞因子应答。
临床怎么用
- 该发现为着色芽生菌病肽基疫苗开发提供了候选表位Hp11696,尚需进一步临床前和临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chromoblastomycosis is a chronic neglected tropical mycosis caused predominantly by the melanized fungus Fonsecaea pedrosoi. Current treatments are prolonged and frequently ineffective, highlighting the need for new therapeutic strategies. Here, we applied an integrated immunoproteomic and reverse vaccinology approach to identify immunogenic antigens from F. pedrosoi and evaluate their vaccine potential. Fungal proteins were separated by two-dimensional electrophoresis and immunoreactive proteins were detected using sera from infected mice. Mass spectrometry identified several antigenic proteins, including enolase and previously uncharacterized hypothetical proteins. Computational epitope prediction revealed a peptide candidate (Hp11696; LGFMSAFKASKLIAI) with high predicted affinity for MHC class II molecules. Functional assays demonstrated that Hp11696 stimulated antigen-specific CD4+ T-cell proliferation in splenocytes derived from infected animals. Immunization with Hp11696 significantly reduced fungal burden in a murine model of chromoblastomycosis and induced cytokine responses characterized by increased IFN-γ and IL-10 production. Collectively, these findings demonstrate that immunoproteomics-guided antigen discovery can identify protective peptide epitopes from fungal pathogens. The Hp11696 peptide represents a promising candidate for the development of peptide-based vaccines targeting chromoblastomycosis.
引用
- de Godoy Menezes I, Pereira BV, Albuquerque RC, et al. Immunoproteomics and reverse vaccinology identify a protective T-cell epitope from Fonsecaea pedrosoi for experimental chromoblastomycosis. Vaccine. 2026. PMID: 42413318. doi:10.1016/j.vaccine.2026.128902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。